dr. karmali on the impact of car t-cell therapy in dlbcl
Published 6 years ago • 395 plays • Length 0:46Download video MP4
Download video MP3
Similar videos
-
0:48
dr. karmali on the future of car t-cell therapy in dlbcl
-
1:59
dr. karmali discusses toxicites associated with car t-cell therapies
-
3:01
candidates for car t-cell therapy in dlbcl
-
1:16
dr. karmali on the importance of evaluating older patients with mcl in the rituximab era
-
1:21
dr. karmali on optimizing maintenance therapy in older patients with mcl
-
0:56
dr. kahl on the potential of car t-cell therapy in mcl
-
8:14
safety and efficacy of car t therapy in r/r dlbcl
-
1:31
dr. karmali on challenges in mcl
-
6:10
car t-cell therapy in managing various lymphomas
-
2:03
dr. schuster dicsusses car t-cell therapy in dlbcl
-
5:03
selecting from car t-cell therapies in dlbcl
-
0:58
dr. karmali on fda approval of kte-c19 in non-hodgkin lymphoma
-
1:12
ann lacasce, md, on car t-cell therapy
-
4:57
car t-cell therapy and the future management of mcl
-
6:13
lymphoma: overview of chimeric antigen receptor (car) t cells
-
1:11
dr. karmali on next steps of research regarding ibrutinib maintenance in mcl
-
1:28
dr. karmali on the toxicity profile of ibrutinib maintenance in mcl
-
2:20
a child's guide side effects of car t-cell therapy
-
0:50
dr. karmali on treating older patients with mcl in the rituximab era